Cargando…
A Novel Trans-Tracheostomal Retrograde Inhalation Technique Increases Subglottic Drug Deposition Compared to Traditional Trans-Oral Inhalation
Subglottic stenosis represents a challenging clinical condition in otolaryngology. Although patients often experience improvement following endoscopic surgery, recurrence rates remain high. Pursuing measures to maintain surgical results and prevent recurrence is thus necessary. Steroids therapy is c...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056688/ https://www.ncbi.nlm.nih.gov/pubmed/36986764 http://dx.doi.org/10.3390/pharmaceutics15030903 |
_version_ | 1785016185046171648 |
---|---|
author | Allon, Raviv Bhardwaj, Saurabh Sznitman, Josué Shoffel-Havakuk, Hagit Pinhas, Sapir Zloczower, Elchanan Shapira-Galitz, Yael Lahav, Yonatan |
author_facet | Allon, Raviv Bhardwaj, Saurabh Sznitman, Josué Shoffel-Havakuk, Hagit Pinhas, Sapir Zloczower, Elchanan Shapira-Galitz, Yael Lahav, Yonatan |
author_sort | Allon, Raviv |
collection | PubMed |
description | Subglottic stenosis represents a challenging clinical condition in otolaryngology. Although patients often experience improvement following endoscopic surgery, recurrence rates remain high. Pursuing measures to maintain surgical results and prevent recurrence is thus necessary. Steroids therapy is considered effective in preventing restenosis. Currently, however, the ability of trans-oral steroid inhalation to reach and affect the stenotic subglottic area in a tracheotomized patient is largely negligible. In the present study, we describe a novel trans-tracheostomal retrograde inhalation technique to increase corticosteroid deposition in the subglottic area. We detail our preliminary clinical outcomes in four patients treated with trans-tracheostomal corticosteroid inhalation via a metered dose inhaler (MDI) following surgery. Concurrently, we leverage computational fluid-particle dynamics (CFPD) simulations in an extra-thoracic 3D airway model to gain insight on possible advantages of such a technique over traditional trans-oral inhalation in augmenting aerosol deposition in the stenotic subglottic region. Our numerical simulations show that for an arbitrary inhaled dose (aerosols spanning 1–12 µm), the deposition (mass) fraction in the subglottis is over 30 times higher in the retrograde trans-tracheostomal technique compared to the trans-oral inhalation technique (3.63% vs. 0.11%). Importantly, while a major portion of inhaled aerosols (66.43%) in the trans-oral inhalation maneuver are transported distally past the trachea, the vast majority of aerosols (85.10%) exit through the mouth during trans-tracheostomal inhalation, thereby avoiding undesired deposition in the broader lungs. Overall, the proposed trans-tracheostomal retrograde inhalation technique increases aerosol deposition rates in the subglottis with minor lower-airway deposition compared to the trans-oral inhalation technique. This novel technique could play an important role in preventing restenosis of the subglottis. |
format | Online Article Text |
id | pubmed-10056688 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100566882023-03-30 A Novel Trans-Tracheostomal Retrograde Inhalation Technique Increases Subglottic Drug Deposition Compared to Traditional Trans-Oral Inhalation Allon, Raviv Bhardwaj, Saurabh Sznitman, Josué Shoffel-Havakuk, Hagit Pinhas, Sapir Zloczower, Elchanan Shapira-Galitz, Yael Lahav, Yonatan Pharmaceutics Article Subglottic stenosis represents a challenging clinical condition in otolaryngology. Although patients often experience improvement following endoscopic surgery, recurrence rates remain high. Pursuing measures to maintain surgical results and prevent recurrence is thus necessary. Steroids therapy is considered effective in preventing restenosis. Currently, however, the ability of trans-oral steroid inhalation to reach and affect the stenotic subglottic area in a tracheotomized patient is largely negligible. In the present study, we describe a novel trans-tracheostomal retrograde inhalation technique to increase corticosteroid deposition in the subglottic area. We detail our preliminary clinical outcomes in four patients treated with trans-tracheostomal corticosteroid inhalation via a metered dose inhaler (MDI) following surgery. Concurrently, we leverage computational fluid-particle dynamics (CFPD) simulations in an extra-thoracic 3D airway model to gain insight on possible advantages of such a technique over traditional trans-oral inhalation in augmenting aerosol deposition in the stenotic subglottic region. Our numerical simulations show that for an arbitrary inhaled dose (aerosols spanning 1–12 µm), the deposition (mass) fraction in the subglottis is over 30 times higher in the retrograde trans-tracheostomal technique compared to the trans-oral inhalation technique (3.63% vs. 0.11%). Importantly, while a major portion of inhaled aerosols (66.43%) in the trans-oral inhalation maneuver are transported distally past the trachea, the vast majority of aerosols (85.10%) exit through the mouth during trans-tracheostomal inhalation, thereby avoiding undesired deposition in the broader lungs. Overall, the proposed trans-tracheostomal retrograde inhalation technique increases aerosol deposition rates in the subglottis with minor lower-airway deposition compared to the trans-oral inhalation technique. This novel technique could play an important role in preventing restenosis of the subglottis. MDPI 2023-03-10 /pmc/articles/PMC10056688/ /pubmed/36986764 http://dx.doi.org/10.3390/pharmaceutics15030903 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Allon, Raviv Bhardwaj, Saurabh Sznitman, Josué Shoffel-Havakuk, Hagit Pinhas, Sapir Zloczower, Elchanan Shapira-Galitz, Yael Lahav, Yonatan A Novel Trans-Tracheostomal Retrograde Inhalation Technique Increases Subglottic Drug Deposition Compared to Traditional Trans-Oral Inhalation |
title | A Novel Trans-Tracheostomal Retrograde Inhalation Technique Increases Subglottic Drug Deposition Compared to Traditional Trans-Oral Inhalation |
title_full | A Novel Trans-Tracheostomal Retrograde Inhalation Technique Increases Subglottic Drug Deposition Compared to Traditional Trans-Oral Inhalation |
title_fullStr | A Novel Trans-Tracheostomal Retrograde Inhalation Technique Increases Subglottic Drug Deposition Compared to Traditional Trans-Oral Inhalation |
title_full_unstemmed | A Novel Trans-Tracheostomal Retrograde Inhalation Technique Increases Subglottic Drug Deposition Compared to Traditional Trans-Oral Inhalation |
title_short | A Novel Trans-Tracheostomal Retrograde Inhalation Technique Increases Subglottic Drug Deposition Compared to Traditional Trans-Oral Inhalation |
title_sort | novel trans-tracheostomal retrograde inhalation technique increases subglottic drug deposition compared to traditional trans-oral inhalation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056688/ https://www.ncbi.nlm.nih.gov/pubmed/36986764 http://dx.doi.org/10.3390/pharmaceutics15030903 |
work_keys_str_mv | AT allonraviv anoveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation AT bhardwajsaurabh anoveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation AT sznitmanjosue anoveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation AT shoffelhavakukhagit anoveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation AT pinhassapir anoveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation AT zloczowerelchanan anoveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation AT shapiragalitzyael anoveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation AT lahavyonatan anoveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation AT allonraviv noveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation AT bhardwajsaurabh noveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation AT sznitmanjosue noveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation AT shoffelhavakukhagit noveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation AT pinhassapir noveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation AT zloczowerelchanan noveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation AT shapiragalitzyael noveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation AT lahavyonatan noveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation |